Gene Therapy in Patients with Limb-Girdle Muscular Dystrophy Type 2E
May 09, 2021•4 min
Episode description
Dr. Louise Rodino-Klapac discusses her abstract, "Safety, β-sarcoglycan Expression and Functional Outcomes from Systemic Gene Transfer of rAAVrh74.MHCK7.SGCB in Patients with Limb-Girdle Muscular Dystrophy Type 2E (LGMD2E)".
You can view her abstract and others here: https://index.mirasmart.com/AAN2021/
For the best experience, listen in Metacast app for iOS or Android
